Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annsa C Huang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2022
National Experience on Waitlist Outcomes for Down-Staging of Hepatocellular Carcinoma: High Dropout Rate in All-ComersAnnsa C Huang, Jennifer L Dodge, Francis Y Yao, et al.
Hepatology (Baltimore, Md.)|February 25, 2018
Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropoutAnnsa C Huang, Neil Mehta, Jennifer L Dodge, et al.
The American Journal of Gastroenterology|December 20, 2021
Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal OutcomesAnnsa C Huang, Joshua Grab, Jennifer A Flemming, et al.
Digestive Diseases and Sciences|December 2, 2022
Achalasia Quality Indicator AdherenceEmily Romanoff, Justin Zhuo, Annsa C Huang, et al.
Transplantation|January 25, 2020
The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter StudyAndre Gorgen, Zita Galvin, Annsa C Huang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2022
National Experience on Waitlist Outcomes for Down-Staging of Hepatocellular Carcinoma: High Dropout Rate in All-ComersAnnsa C Huang, Jennifer L Dodge, Francis Y Yao, et al.
Hepatology (Baltimore, Md.)|February 25, 2018
Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropoutAnnsa C Huang, Neil Mehta, Jennifer L Dodge, et al.
The American Journal of Gastroenterology|December 20, 2021
Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal OutcomesAnnsa C Huang, Joshua Grab, Jennifer A Flemming, et al.
Digestive Diseases and Sciences|December 2, 2022
Achalasia Quality Indicator AdherenceEmily Romanoff, Justin Zhuo, Annsa C Huang, et al.
Transplantation|January 25, 2020
The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter StudyAndre Gorgen, Zita Galvin, Annsa C Huang, et al.
Pageof 1